Stock Events

Stock Events

Relmada Therapeutics (4E2.STU) Q2 2026 Earnings

12MayConfirmed

Q1 2026

Next

-0.23

-0.2

-0.16

-0.13

Details

Expected EPS

-0.16994842200000002

Actual EPS

N/A

Surprise EPS

0.17

Surprise Percent

+100%

Description

Relmada Therapeutics (4E2.STU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.